FTHFX
Price
$58.72
Change
+$0.60 (+1.03%)
Updated
Sep 11 closing price
Net Assets
12.15B
SKSEX
Price
$35.30
Change
+$0.13 (+0.37%)
Updated
Sep 11 closing price
Net Assets
224.05M
Interact to see
Advertisement

FTHFX vs SKSEX

FTHFX vs SKSEX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. SKSEX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and SKSEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 12.1B vs. SKSEX (224M). FTHFX pays higher dividends than SKSEX: FTHFX (0.56) vs SKSEX (0.48). FTHFX was incepted earlier than SKSEX: FTHFX (15 years) vs SKSEX (39 years). SKSEX (1.20) is less costly to investors than FTHFX (0.64). SKSEX is a more actively managed with annual turnover of: 36.00 vs. FTHFX (28.00). SKSEX has a lower initial minimum investment than FTHFX: SKSEX (2000) vs FTHFX (1000000). FTHFX annual gain was more profitable for investors over the last year : 15.30 vs. SKSEX (12.75). FTHFX return over 5 years is better than : 60.92 vs. SKSEX (24.67).
FTHFXSKSEXFTHFX / SKSEX
Total Expense Ratio0.641.1556%
Annual Report Gross Expense Ratio0.641.2053%
Fund Existence15 years39 years-
Gain YTD14.83921.06770%
Front LoadN/AN/A-
Min. Initial Investment1000000200050,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B224M5,402%
Annual Yield % from dividends0.560.48118%
Returns for 1 year15.3012.75120%
Returns for 3 years58.6830.86190%
Returns for 5 years60.9224.67247%
Returns for 10 years237.29-3.18-7,456%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SLON32.011.50
+4.92%
ProShares Ultra Solana ETF
IBUY68.420.78
+1.16%
Amplify Online Retail ETF
FLDB50.280.02
+0.03%
Fidelity Low Duration Bond ETF
FLDR49.93-0.03
-0.06%
Fidelity Low Duration Bond Factor ETF
HELX40.99-0.04
-0.11%
Franklin Genomic Advancements ETF